Delivery Order SPE2DE24D0013-SPE2D626F41ZA
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,277.84 to Cepheid Inc. (Sunnyvale, CA) on January 14, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger indefinite delivery contract vehicle and represents a child contract action. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, provides the GeneXpert diagnostic...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,194.60 to Cepheid Inc. on January 28, 2026, with an ultimate completion date of February 4, 2026. This firm fixed-price delivery order, issued under contract GXCT/NG-10 with no set-aside designation, represents a child contract utilizing an existing indefinite delivery vehicle. Cepheid, headquartered in Sunnyvale, California, is a specialized manufacturer of advanced molecular diagnostic systems and reagents,...
- The Defense Logistics Agency Medical Supply Chain awarded a $4,320 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, on February 3, 2026, with an ultimate completion date of February 10, 2026. This firm fixed-price delivery order, designated as a child contract with no set-aside designation, represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic solutions to the Defense Health Agency...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,530.08 to Cepheid Inc. on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a relatively modest procurement within Cepheid's broader federal contract portfolio. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier. Performance will take place at...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,160 firm fixed-price delivery order to Cepheid Inc. on January 8, 2026, with an ultimate completion date of January 15, 2026. This delivery order, issued under contract number GXMRSA-NXG-10, represents a child contract with no set-aside designation and is for performance at Cepheid's headquarters location in Sunnyvale, California. As a leading manufacturer of molecular diagnostic systems and reagents, Cepheid supplies critical...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,757.00 firm fixed-price delivery order to Cepheid Inc. on November 5, 2025, with an ultimate completion date of November 20, 2025. This delivery order, issued without a set-aside designation, supports the agency's molecular diagnostic supply requirements and leverages Cepheid's established expertise as a primary federal supplier of diagnostic solutions. The work will be performed at Cepheid's headquarters in Sunnyvale, California....
- The Defense Logistics Agency Medical Supply Chain awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on January 30, 2026, under contract XPRS4PLEX-10, with an ultimate completion date of February 6, 2026. This delivery order, which is not set-aside designated, represents a child contract issued to the Sunnyvale, California-based molecular diagnostics manufacturer. Cepheid specializes in advanced diagnostic systems and reagents, with particular expertise in the GeneXpert...
- The Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $3,500 to Cepheid Inc. on February 4, 2026, with an ultimate completion date of February 11, 2026. This delivery order, issued without set-aside designation, is a child contract under a larger indefinite delivery vehicle and represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic solutions. Cepheid, headquartered in Sunnyvale, California, specializes in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,376.76 to Cepheid Inc. on February 3, 2026, with an ultimate completion date of February 10, 2026. This firm fixed-price delivery order, designated as GXCT/NG-10, represents a child contract under a larger indefinite delivery vehicle. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics marketplace. Performance will take place at...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,440 firm fixed-price delivery order to Cepheid Inc. on December 1, 2025, with an ultimate completion date of December 8, 2025. This delivery order, issued under contract number 4570137197, represents a procurement of molecular diagnostic supplies or reagents from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic testing systems. The award carries no set-aside designation, reflecting Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F41ZADelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,271.00 to Cepheid Inc. on February 3, 2026, with an ultimate completion date of February 18, 2026. This firm fixed-price delivery order, issued under contract 4570715071, represents a child contract with no set-aside designation and will be performed at Cepheid's Sunnyvale, California facility. As a prime contractor, Cepheid is a leading manufacturer of advanced molecular diagnostic systems and reagents, with established relationships across multiple federal healthcare agencies including the Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. This delivery order falls within Cepheid's broader federal contracting portfolio, which includes significant indefinite delivery contracts with the Department of Veterans Affairs and multiple procurement vehicles across the Defense Logistics Agency. Cepheid's core competencies encompass the GeneXpert diagnostic platform and associated molecular testing capabilities for infectious disease detection, including COVID-19, influenza, tuberculosis, and other conditions. The modest contract value reflects a routine supply or service order typical of the company's consistent firm fixed-price delivery orders supporting federal healthcare operations and diagnostic testing requirements across the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 2/2/26 |